126.96
price up icon0.41%   0.52
after-market 시간 외 거래: 127.00 0.04 +0.03%
loading
전일 마감가:
$126.44
열려 있는:
$126.39
하루 거래량:
523.17K
Relative Volume:
0.64
시가총액:
$7.47B
수익:
$633.51M
순이익/손실:
$-8.10M
주가수익비율:
-409.55
EPS:
-0.31
순현금흐름:
$131.26M
1주 성능:
+2.37%
1개월 성능:
+7.08%
6개월 성능:
-11.25%
1년 성능:
+5.68%
1일 변동 폭
Value
$125.62
$128.19
1주일 범위
Value
$121.44
$131.43
52주 변동 폭
Value
$102.97
$182.52

Repligen Corp Stock (RGEN) Company Profile

Name
명칭
Repligen Corp
Name
전화
(781) 449-9560
Name
주소
41 SEYON STREET, WALTHAM, MA
Name
직원
1,778
Name
트위터
@repligen
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
RGEN's Discussions on Twitter

RGEN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Instruments & Supplies icon
RGEN
Repligen Corp
126.96 7.47B 633.51M -8.10M 131.26M -0.31
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
540.60 189.82B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
177.27 49.98B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
89.30 44.00B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
255.88 37.05B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
221.22 16.36B 2.90B 467.20M 306.90M 6.37

Repligen Corp Stock (RGEN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-29 업그레이드 Wolfe Research Peer Perform → Outperform
2025-03-18 개시 Evercore ISI In-line
2025-02-10 개시 TD Cowen Buy
2024-12-17 개시 Canaccord Genuity Hold
2024-11-14 개시 Wolfe Research Peer Perform
2024-08-28 개시 Wells Fargo Overweight
2024-06-26 업그레이드 Deutsche Bank Hold → Buy
2024-06-18 개시 Guggenheim Neutral
2023-12-04 다운그레이드 The Benchmark Company Buy → Hold
2023-07-20 개시 Wells Fargo Overweight
2023-07-05 재개 JP Morgan Overweight
2023-03-28 개시 The Benchmark Company Buy
2022-12-14 개시 Deutsche Bank Hold
2022-12-07 개시 RBC Capital Mkts Sector Perform
2022-07-20 개시 UBS Buy
2021-10-14 개시 Exane BNP Paribas Outperform
2020-11-10 개시 KeyBanc Capital Markets Overweight
2020-08-24 재확인 H.C. Wainwright Buy
2020-06-30 재확인 H.C. Wainwright Buy
2020-05-07 재확인 H.C. Wainwright Buy
2020-03-23 재확인 H.C. Wainwright Buy
2019-11-15 개시 Stifel Buy
2019-11-01 업그레이드 First Analysis Sec Outperform → Strong Buy
2019-10-15 개시 SVB Leerink Outperform
2019-08-28 재확인 First Analysis Sec Outperform
2019-08-23 재개 Stephens Overweight
2019-07-22 업그레이드 H.C. Wainwright Neutral → Buy
2018-12-17 업그레이드 CL King Neutral → Buy
2018-11-12 다운그레이드 CL King Buy → Neutral
2018-09-26 개시 H.C. Wainwright Neutral
2017-12-08 개시 Citigroup Buy
2017-12-05 개시 JP Morgan Overweight
2017-11-13 개시 CL King Buy
2017-10-02 업그레이드 First Analysis Sec Equal-Weight → Overweight
2017-07-21 개시 William Blair Outperform
2017-02-13 업그레이드 Piper Jaffray Neutral → Overweight
모두보기

Repligen Corp 주식(RGEN)의 최신 뉴스

pulisher
Jun 16, 2025

Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Jun 16, 2025
pulisher
Jun 16, 2025

Yousif Capital Management LLC Has $2.01 Million Position in Repligen Co. (NASDAQ:RGEN) - Defense World

Jun 16, 2025
pulisher
Jun 13, 2025

Does Repligen Corp (RGEN) Have a Strong Pricing Power? - Insider Monkey

Jun 13, 2025
pulisher
Jun 11, 2025

Repligen Co. (NASDAQ:RGEN) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Parallel Advisors LLC Has $36,000 Stock Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World

Jun 10, 2025
pulisher
Jun 04, 2025

Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

Repligen at William Blair Conference: Innovation Drives Growth By Investing.com - Investing.com Canada

Jun 03, 2025
pulisher
Jun 03, 2025

Repligen at William Blair Conference: Innovation Drives Growth - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Repligen Corp (RGEN) Stock Price Up 5% on Jun 3 - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Drug Development Inputs & Services Stocks Q1 In Review: Repligen (NASDAQ:RGEN) Vs Peers - Yahoo Finance

Jun 03, 2025
pulisher
Jun 02, 2025

Do Options Traders Know Something About Repligen (RGEN) Stock We Don't? - Yahoo Finance

Jun 02, 2025
pulisher
May 31, 2025

Repligen Corp (RGEN) Trading Down 3.33% on May 30 - GuruFocus

May 31, 2025
pulisher
May 29, 2025

Why Is Repligen (RGEN) Down 12.2% Since Last Earnings Report? - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Cetera Investment Advisers Has $436,000 Position in Repligen Co. (NASDAQ:RGEN) - Defense World

May 29, 2025
pulisher
May 27, 2025

Repligen Corp (RGEN) Stock Price Up 4.35% on May 27 - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Repligen Announces Publication of the Company's 2024 Corporate Sustainability Report - The Manila Times

May 27, 2025
pulisher
May 27, 2025

Repligen Announces Publication of the Company’s 2024 Corporate Sustainability Report - TradingView

May 27, 2025
pulisher
May 27, 2025

Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges - Investing.com

May 27, 2025
pulisher
May 27, 2025

Repligen’s SWOT analysis: bioprocessing leader’s stock faces growth challenges By Investing.com - Investing.com UK

May 27, 2025
pulisher
May 22, 2025

Repligen Corporation to Present at William Blair Growth Conference - Yahoo Finance

May 22, 2025
pulisher
May 20, 2025

Repligen at RBC Capital Markets: Strategic Growth Insights - Investing.com Australia

May 20, 2025
pulisher
May 17, 2025

Insider Sell: Anthony Hunt Sells 26,447 Shares of Repligen Corp (RGEN) - GuruFocus

May 17, 2025
pulisher
May 17, 2025

Repligen Co. (NASDAQ:RGEN) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

May 17, 2025
pulisher
May 16, 2025

Mercer Global Advisors Inc. ADV Sells 1,039 Shares of Repligen Co. (NASDAQ:RGEN) - Defense World

May 16, 2025
pulisher
May 16, 2025

Contrasting Repligen (NASDAQ:RGEN) & Maze Therapeutics (NASDAQ:MAZE) - Defense World

May 16, 2025
pulisher
May 15, 2025

Pioneering innovation in bioprocessing: Repligen’s growing impact in the area and symbiotic relationship with WWETB - Business Post

May 15, 2025
pulisher
May 13, 2025

Why Repligen Corp Stock Might Make Sense If Bought Today - Stocksregister

May 13, 2025
pulisher
May 12, 2025

Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know - Yahoo Finance

May 12, 2025
pulisher
May 11, 2025

Stifel Financial Corp Grows Holdings in Repligen Co. (NASDAQ:RGEN) - Defense World

May 11, 2025
pulisher
May 08, 2025

Things To Consider Before Buying Repligen Corp (NASDAQ: RGEN) - Stocksregister

May 08, 2025
pulisher
May 08, 2025

Global Hollow Fiber Filtration Market Set to Witness - openPR.com

May 08, 2025
pulisher
May 08, 2025

M&A activity dominates Q1, nearly 99% total med-tech deal value - BioWorld MedTech

May 08, 2025
pulisher
May 08, 2025

Repligen (NASDAQ:RGEN) Upgraded to “Hold” at StockNews.com - Defense World

May 08, 2025
pulisher
May 07, 2025

Investor’s Toolkit: Key Ratios for Assessing Repligen Corp (RGEN)’s Performance - DWinneX

May 07, 2025
pulisher
May 07, 2025

Repligen Corporation to Present at Upcoming May Investor Conferences - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

Repligen (NASDAQ:RGEN) Given Buy Rating at HC Wainwright - Defense World

May 06, 2025
pulisher
May 05, 2025

Repligen (RGEN) Maintains Buy Rating with $180 Price Target | RG - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Repligen (RGEN) Maintains Buy Rating with $180 Price Target | RGEN Stock News - GuruFocus

May 05, 2025
pulisher
May 03, 2025

Leerink Partnrs Has Pessimistic View of Repligen Q2 Earnings - Defense World

May 03, 2025
pulisher
May 02, 2025

Repligen Corp. (RGEN) Slid On Uncertainty Related To U.S. Federal Government Spending On Healthcare - Insider Monkey

May 02, 2025
pulisher
May 01, 2025

There is no doubt that Repligen Corp (RGEN) ticks all the boxes. - Sete News

May 01, 2025
pulisher
May 01, 2025

Jim Cramer on Repligen Corporation (RGEN): ‘I’m Not Quite Ready to Stick My Neck Out on This One’ - Insider Monkey

May 01, 2025
pulisher
May 01, 2025

Wolfe Research Upgrades Repligen (NASDAQ:RGEN) to “Outperform” - Defense World

May 01, 2025
pulisher
May 01, 2025

BlackRock, Inc. Reduces Stake in Repligen Corp: An In-Depth Anal - GuruFocus

May 01, 2025
pulisher
Apr 30, 2025

Jim Cramer Listed 20 Best Performing Stocks of the Last 20 Years - Insider Monkey

Apr 30, 2025
pulisher
Apr 30, 2025

Deep Dive Into Repligen Stock: Analyst Perspectives (8 Ratings) - Benzinga

Apr 30, 2025
pulisher
Apr 30, 2025

Wolfe Research Upgrades Repligen Corp (RGEN) to an Outperform from a Peer perform - knoxdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

RGEN Q1 Earnings Call: Repligen Delivers Above-Consensus Revenue, Raises Sales Outlook Amid Tariff Uncertainty - Yahoo Finance

Apr 30, 2025
pulisher
Apr 30, 2025

Repligen (RGEN) Price Target Adjusted by RBC Capital Amid Market Trends | RGEN Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

Repligen's Q1 Earnings Beat Estimates, Revenues Surge Y/Y - Barchart.com

Apr 30, 2025
pulisher
Apr 30, 2025

Repligen Corporation (NASDAQ:RGEN) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 30, 2025

Repligen Corp (RGEN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$78.25
price up icon 0.46%
$196.98
price up icon 1.39%
medical_instruments_supplies COO
$73.02
price up icon 0.29%
$65.30
price down icon 0.05%
medical_instruments_supplies BAX
$31.13
price down icon 0.32%
medical_instruments_supplies WST
$221.22
price down icon 0.54%
자본화:     |  볼륨(24시간):